KRTAP19-7 inhibitors are a class of chemical compounds that specifically target and modulate the activity of keratin-associated proteins (KRTAPs), with a focus on the KRTAP19-7 subtype. KRTAPs are a group of proteins that contribute to the structure and function of keratin filaments, primarily in hair and nail formation. KRTAP19-7, in particular, is involved in hair fiber assembly and plays a crucial role in maintaining the physical properties of hair, such as its strength, elasticity, and resilience. Inhibitors targeting KRTAP19-7 are designed to interfere with its interaction with keratin filaments or affect its expression, which may lead to alterations in the structure or function of the hair matrix.
The chemical structures of KRTAP19-7 inhibitors can vary significantly, ranging from small molecules to peptides, and are typically designed to interact with the specific binding sites or regulatory regions of KRTAP19-7. These inhibitors may function by disrupting protein-protein interactions within the hair cortex or altering the post-translational modifications of KRTAP19-7, affecting its ability to stabilize keratin filaments. Some inhibitors may also influence the biochemical pathways regulating KRTAP19-7 synthesis or degradation, leading to changes in its cellular levels. By modulating KRTAP19-7 activity, these inhibitors provide valuable tools for studying the molecular dynamics of keratin-associated proteins and the broader processes of hair and nail formation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent could hypothetically induce hypomethylation of the KRTAP19-7 gene promoter, leading to a shutdown of its transcription initiation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A could potentially lead to an open chromatin state at the KRTAP19-7 locus, resulting in transcriptional repression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A might bind to DNA in the promoter region of KRTAP19-7, obstructing the binding of essential transcriptional activators and thereby decreasing KRTAP19-7 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound could intercalate into the DNA of the KRTAP19-7 gene, obstructing the advancement of RNA polymerase and leading to a reduction in KRTAP19-7 mRNA synthesis. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 may inhibit DNA methylation enzymes, potentially leading to a decrease in the methylation status of the KRTAP19-7 promoter and a subsequent reduction in gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This chemical could induce DNA demethylation, potentially resulting in the silencing of KRTAP19-7 gene expression through epigenetic remodeling. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
By inhibiting histone deacetylases, Suberoylanilide Hydroxamic Acid could lead to alterations in histone acetylation at the KRTAP19-7 gene, promoting transcriptional silencing. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin might downregulate KRTAP19-7 expression by inhibiting the mTOR pathway, which is crucial for the transcription of certain genes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This compound could potentially repress the transcription factor machinery necessary for KRTAP19-7 expression, leading to a decrease in its gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might inhibit the transcriptional machinery or signaling pathways necessary for the expression of the KRTAP19-7 gene, leading to its downregulation. | ||||||